Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis.
about
The subunit composition of the human NADH dehydrogenase obtained by rapid one-step immunopurificationOlesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosisA comprehensive review of amyotrophic lateral sclerosisAberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic miceMitochondrial dysfunction and intracellular calcium dysregulation in ALSMisfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALSMitochondrial network genes in the skeletal muscle of amyotrophic lateral sclerosis patientsMitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.Increased axonal mitochondrial mobility does not slow amyotrophic lateral sclerosis (ALS)-like disease in mutant SOD1 mice.Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis.TRPM7 and TRPM2-Candidate susceptibility genes for Western Pacific ALS and PD?Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral SclerosisMitochondria in amyotrophic lateral sclerosis: a trigger and a target.More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases.The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy.Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach.The interplay between metabolic homeostasis and neurodegeneration: insights into the neurometabolic nature of amyotrophic lateral sclerosis.The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis.Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.Degeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates.Mitochondrial respiratory chain function in skeletal muscle of ALS patients.Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.Reduced exercise capacity in early-stage amyotrophic lateral sclerosis: Role of skeletal muscle.Energy metabolism in ALS: an underappreciated opportunity?Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.Synaptic Failure: Focus in an Integrative View of ALS.Abnormalities of satellite cells function in amyotrophic lateral sclerosisA prospective study to evaluate the impact of31P‐MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patientsMitochondrial genome aberrations in skeletal muscle of patients with motor neuron disease
P2860
Q24296439-A91528CD-7DFD-4F06-8424-4CB6927B81CEQ24596378-2AA3E0DA-D341-4EAD-8BCD-66130C91F9C7Q26775401-60FD9AD1-4989-43F0-BB00-12E3D5DDEEF4Q30552760-F3540D1B-DF07-421F-B7D1-7CC55E57F6B8Q33783000-88BAF687-CFE6-4015-9207-00F9B0E0A1CCQ33832905-6CD5AD47-A952-4FF9-A0CC-C527DB22D797Q34103782-4D7E7404-8587-4F6C-A664-07D1991BF323Q34139970-9AF05AC0-0A2C-4BCB-A57A-A89BA965AEE5Q34612409-2E435948-DA66-41A9-AF4B-E01886128BDBQ34981294-B9CC93A1-CD01-4923-BD13-B65C709F3A47Q35067857-3EBFE91B-02B7-4FC7-9506-C7C0DA99A64CQ35987553-7BF7D7F1-51C1-4F4B-9336-FE2484915B99Q36015320-9C68D81A-E1C4-4462-9264-E7EA6EDD446DQ36114275-17ADAD5F-52D3-4438-AD8B-534932244A4BQ36565597-B93FD50F-1B26-455D-823F-D794B0E6A4B0Q37400655-F3181F97-9E05-4989-A562-C31C291501C8Q37466115-D8246FFE-5FAA-4E35-B10F-0FCBEA094066Q37775036-A48F8519-0EE4-4ED1-9D5E-8BBE205CEEDCQ38575783-FC525897-2F91-4A26-9A7C-ED1300487A75Q38577066-3197269C-16A7-4B6D-8EED-DFE8C39E9EB8Q38701055-8C925835-D620-4098-9FD9-2B1E47B91C02Q40233562-54CAE305-277F-4148-93B3-A9F240C6DD73Q40609007-C74591DD-1B67-40B1-ACF9-035973C526C9Q42527324-4A9F9243-5D2E-4986-BF4E-67CD65209804Q42634243-2F0FA537-98FF-4F42-A1AA-0DABACC6B703Q45347278-5B90A181-0A97-4F01-81D5-C20C5238AEC6Q52651163-2F787578-C349-4DBF-93AA-26A3C1A19EF9Q55004580-253E6A56-D5D9-4BE9-944F-420A34981F31Q55233896-A1B7F0CF-FD46-4A0E-9204-11C86AA402BCQ57268487-26B42BA7-EDCD-4F91-8A58-F5BB6C14F014Q58145730-01791F03-FEE9-4CE8-8DF6-F52B4CD957A6Q58270225-1083304C-20F4-4C30-83A0-22C328FD75B1
P2860
Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@ast
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@en
type
label
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@ast
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@en
prefLabel
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@ast
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@en
P2093
P1476
Visualization of defective mit ...... amyotrophic lateral sclerosis.
@en
P2093
Feistner H
Ludolph AC
Vielhaber S
P304
P356
10.1016/S0022-510X(99)00236-1
P577
1999-10-01T00:00:00Z